Cargando…
Rituximab for the treatment of connective tissue disease–associated interstitial lung disease: A systematic review and meta-analysis
Background: Interstitial lung disease (ILD) is a common pulmonary disease often associated with significant morbidity and mortality in patients with connective tissue diseases (CTD). Currently, no gold-standard therapies are available for CTD-ILD. Recently, several studies have proposed that rituxim...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9650441/ https://www.ncbi.nlm.nih.gov/pubmed/36386239 http://dx.doi.org/10.3389/fphar.2022.1019915 |